• About us
• Contact

Advertisement

Organisation › Details

Brandon Capital (Group)

Brandon Capital is Australasia’s leading life science venture capital firm, with an international presence and team members across the US and UK. From early-stage seed investment through to expansion capital, Brandon Capital supports life science companies from proof-of-concept through to commercialisation. Our venture model is unique: we don’t just provide investment, we partner with inventors, entrepreneurs and research organisations, providing hands-on support and expertise to increase their chance of success. Brandon BioCatalyst, Brandon Capital’s Australasian-based collaboration, brings together 50 trans-Tasman medical research institutes, investors, and governments all united in progressing the next generation of medical therapies and technology. Brandon BioCatalyst supports the development and commercialisation of early-stage biomedical discoveries associated with member research organisations, providing both capital and expertise to guide the successful development of new therapies. *

 

	Start	2007-01-01 established
	Industry	investment management
	Industry 2	LIFE SCIENCES
	Person	Thompson, Stephen (Brandon Capital 202011 formerly at Apax Partners)
	Person 2	Tobin, Jonathan (Brandon Capital 202209 Partner before Arix Bioscience 201706)
	Region	Melbourne VIC
	Country	Australia
	Street	31 Queen Street Level 9
	City	3000 Melbourne VIC
	Tel	+61-3-9657-0700
		Address record changed: 2024-06-08
Basic data	Employees	n. a.
	Currency	AUD
	Annual sales	800,000,000 (funds, managed (2019) 2019-12-18)
		* Document for »About Section«: Catalym GmbH. (11/22/22). "Press Release: Catalym Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors". Oxford.
		Record changed: 2024-06-08

Advertisement

More documents for Brandon Capital (Group)

• [1] Brandon Capital. (6/4/24). "Press Release: Brandon Capital Announces Sixth Fund with A$270 Million (US$180 Million) Initial Close to Drive Life Science Innovation". Melbourne....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.